论文部分内容阅读
美国FDA 1983年批准的新药总数为14个,仅相当于1982年批准新药的一半。1982年和1981年分别批准28个和27个。 (1) Acetohydroxamine泌尿科新药。由Uro-Research Inc.研制。 (2) Altracurium besylate神经肌肉阻断剂。由Burrough-wellcome药厂研制。 (3) Bentiromide诊断用药。用于胰脏外分泌不足的筛选试验。由Adria公司开发。 (4) Bumetanide利尿药。由Roche药厂研制。
The total number of new drugs approved by the U.S. FDA in 1983 was 14, equivalent to only half of the new drugs approved in 1982. In 1982 and 1981, respectively, 28 and 27 were approved. (1) Acetohydroxamine Urology new drug. Developed by Uro-Research Inc. (2) Altracurium besylate neuromuscular blockers. Developed by Burrough-wellcome Pharmaceuticals. (3) Bentiromide diagnostic medication. Screening test for pancreatic exocrine insufficiency. Developed by Adria. (4) Bumetanide diuretics. Developed by Roche Pharmaceuticals.